These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 3877338)

  • 41. Type IIB mutation His-505-->Asp implicates a new segment in the control of von Willebrand factor binding to platelet glycoprotein Ib.
    Rabinowitz I; Randi AM; Shindler KS; Tuley EA; Rustagi PK; Sadler JE
    J Biol Chem; 1993 Sep; 268(27):20497-501. PubMed ID: 8376405
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Type IIB von Willebrand's disease associated with a complex thrombocytopenic thrombocytopathy.
    López-Fernández MF; López-Berges C; Martín-Bernal JA; Sánchez R; Villarón LG; Díez-Jarilla J; Batlle J
    Am J Hematol; 1988 Apr; 27(4):291-8. PubMed ID: 3258474
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional analysis of a type IIB von Willebrand disease missense mutation: increased binding of large von Willebrand factor multimers to platelets.
    Cooney KA; Lyons SE; Ginsburg D
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2869-72. PubMed ID: 1557393
    [TBL] [Abstract][Full Text] [Related]  

  • 44. von Willebrand's variant (type II Buffalo). Thrombocytopenia after desmopressin but absence of in vitro hypersensitivity to ristocetin.
    Sweeney JD; Hoernig LA; Behrens AN; Novak E; Swank RT
    Am J Clin Pathol; 1990 Apr; 93(4):522-5. PubMed ID: 2321583
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanisms of platelet aggregation by Streptococcus sanguis, a causative organism in infective endocarditis.
    Ford I; Douglas CW; Preston FE; Lawless A; Hampton KK
    Br J Haematol; 1993 May; 84(1):95-100. PubMed ID: 8338784
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Type 2M von Willebrand disease variant characterized by abnormal von willebrand factor multimerization.
    Casonato A; Pontara E; Sartorello F; Bertomoro A; Durante C; Girolami A
    J Lab Clin Med; 2001 Jan; 137(1):70-6. PubMed ID: 11150026
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The rapid differentiation of type IIb von Willebrand's disease from platelet-type (pseudo-) von Willebrand's disease by the "neutral" monoclonal antibody binding assay.
    Scott JP; Montgomery RR
    Am J Clin Pathol; 1991 Dec; 96(6):723-8. PubMed ID: 1746488
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discrepant increase in factor VIII: C and von Willebrand factor after DDAVP infusion in a patient with variant von Willebrand's disease.
    Casonato A; Sartori MT; Pontara E; Bertomoro A; Dannhäuser D; Girolami
    Blood Coagul Fibrinolysis; 1991 Aug; 2(4):567-73. PubMed ID: 1768767
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heterogeneity of type I von Willebrand disease: evidence for a subgroup with an abnormal von Willebrand factor.
    Mannucci PM; Lombardi R; Bader R; Vianello L; Federici AB; Solinas S; Mazzucconi MG; Mariani G
    Blood; 1985 Oct; 66(4):796-802. PubMed ID: 3876122
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vivo interaction of von Willebrand factor with platelets following cryoprecipitate transfusion in platelet-type von Willebrand's disease.
    Miller JL; Boselli BD; Kupinski JM
    Blood; 1984 Jan; 63(1):226-30. PubMed ID: 6418233
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An atypical von Willebrand's disease with hyperreactivity of platelet aggregation.
    Niiya K; Kubonishi I; Taguchi H; Miyoshi I
    Acta Haematol; 1984; 71(3):158-64. PubMed ID: 6424380
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A new congenital platelet abnormality characterized by spontaneous platelet aggregation, enhanced von Willebrand factor platelet interaction, and the presence of all von Willebrand factor multimers in plasma.
    Casonato A; De Marco L; Mazzucato M; De Angelis V; De Roia D; Fabris F; Ruggeri ZM; Girolami A
    Blood; 1989 Nov; 74(6):2028-33. PubMed ID: 2804346
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hyper-responsiveness to DDAVP for patients with type I von Willebrand's disease and normal intra-platelet von Willebrand factor.
    Rodeghiero F; Castaman G; Di Bona E; Ruggeri M; Lombardi R; Mannucci PM
    Eur J Haematol; 1988 Feb; 40(2):163-7. PubMed ID: 3126081
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Spontaneous platelet aggregation in type IIB Tampa von Willebrand disease is inhibited by the 52/48-kDa fragment of normal von Willebrand factor, which contains the GPIb binding domain.
    Saba HI; Fujimura Y; Saba SR; Bruce AC; Morelli GA; Ruggeri ZM; Zimmerman TS
    Am J Hematol; 1989 Mar; 30(3):150-3. PubMed ID: 2783833
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
    Michiels JJ; Gadisseur A; Vangenegten I; Schroyens W; Berneman Z
    Acta Haematol; 2009; 121(2-3):119-27. PubMed ID: 19506358
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
    Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
    Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Platelet activation and aggregation induced by recombinant von Willebrand factors reproducing four type 2B von Willebrand disease missense mutations.
    de Romeuf C; Hilbert L; Mazurier C
    Thromb Haemost; 1998 Jan; 79(1):211-6. PubMed ID: 9459349
    [TBL] [Abstract][Full Text] [Related]  

  • 58. von Willebrand factor bound to glycoprotein Ib is cleared from the platelet surface after platelet activation by thrombin.
    Hourdillé P; Gralnick HR; Heilmann E; Derlon A; Ferrer AM; Vezon G; Nurden AT
    Blood; 1992 Apr; 79(8):2011-21. PubMed ID: 1562727
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation.
    De Marco L; Girolami A; Russell S; Ruggeri ZM
    J Clin Invest; 1985 Apr; 75(4):1198-203. PubMed ID: 3157702
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Autosomal dominant C1149R von Willebrand disease: phenotypic findings and their implications.
    Pérez-Rodríguez A; García-Rivero A; Lourés E; López-Fernández MF; Rodríguez-Trillo A; Batlle J
    Haematologica; 2009 May; 94(5):679-86. PubMed ID: 19286880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.